Published in Mol Ecol on April 01, 2001
Fitness reduction and potential extinction of wild populations of Atlantic salmon, Salmo salar, as a result of interactions with escaped farm salmon. Proc Biol Sci (2003) 4.84
Age structure, changing demography and effective population size in Atlantic salmon (Salmo salar). Genetics (2009) 0.97
Population connectivity: dam migration mitigations and contemporary site fidelity in arctic char. BMC Evol Biol (2011) 0.80
Selective recovery of founder genetic diversity in aquacultural broodstocks and captive, endangered fish populations. Genetica (2001) 0.79
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature (1999) 3.20
A critical review of adaptive genetic variation in Atlantic salmon: implications for conservation. Biol Rev Camb Philos Soc (2007) 2.98
Variation in river water temperatures in an upland stream over a 30-year period. Sci Total Environ (2001) 2.03
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol (2000) 1.75
The effects of epithelium removal on the sensitivity of guinea-pig isolated trachealis to bronchodilator drugs. Br J Pharmacol (1986) 1.50
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol (1999) 1.47
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther (2000) 1.37
Airway epithelium modulates the reactivity of guinea-pig respiratory smooth muscle. Eur J Pharmacol (1986) 1.35
Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol (1998) 1.25
Epithelium removal increases the reactivity of human isolated tracheal muscle to methacholine and reduces the effect of verapamil. Eur J Pharmacol (1986) 1.17
Demonstration of the release of an epithelium-derived inhibitory factor from a novel preparation of guinea-pig trachea. Eur J Pharmacol (1987) 1.16
Relaxation of guinea-pig tracheal smooth muscle to arachidonate is converted to contraction following epithelium removal. Br J Pharmacol (1987) 1.11
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J Pharmacol Exp Ther (1994) 1.10
Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcal M proteins. J Immunol (2000) 1.08
Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airways. Am J Respir Crit Care Med (1995) 1.07
Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther (1993) 1.06
Epithelium modulates the reactivity of ovalbumin-sensitized guinea-pig airway smooth muscle. Life Sci (1986) 1.06
Airway epithelium-derived inhibitory factor. Trends Pharmacol Sci (1990) 1.05
Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther (1989) 1.05
Effects of some organic calcium antagonists and other procedures affecting Ca2+ Translocation on KCl-induced contractions in the rat vas deferens. Br J Pharmacol (1982) 1.04
Fine sediment influence on salmonid spawning habitat in a lowland agricultural stream: a preliminary assessment. Sci Total Environ (2001) 1.02
Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol (2000) 1.02
Local anaesthetic activity of organic calcium antagonists: relevance to their actions on smooth muscle. Eur J Pharmacol (1982) 1.01
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. J Pharmacol Exp Ther (2000) 1.00
The effect of verapamil is reduced in isolated airway smooth muscle preparations lacking the epithelium. Life Sci (1986) 0.99
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations. Genes Immun (2007) 0.99
Endothelin-1-induced potentiation of human airway smooth muscle proliferation: an ETA receptor-mediated phenomenon. Br J Pharmacol (1996) 0.97
Receptors for endothelin-1 in asthmatic human peripheral lung. Br J Pharmacol (1995) 0.96
Expression and function of voltage-dependent potassium channel genes in human airway smooth muscle. J Biol Chem (1996) 0.94
Auxotrophic mutation and infectivity of Agrobacterium tumefaciens. J Bacteriol (1965) 0.94
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol Pharmacol (1999) 0.93
Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats. Br J Pharmacol (1999) 0.93
The antitussive activity of delta-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther (2000) 0.92
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. J Pharmacol Exp Ther (1998) 0.88
Odorant receptor gene expression changes during the parr-smolt transformation in Atlantic salmon. Mol Ecol (2004) 0.88
Effects of KCl on 45Ca uptake and efflux in the rat vas deferens. Br J Pharmacol (1984) 0.88
Is the guinea pig trachea a good in vitro model of human large and central airways? Comparison on leukotriene-, methacholine-, histamine- and antigen-induced contractions. J Pharmacol Exp Ther (1987) 0.88
Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist. J Pharmacol Exp Ther (1998) 0.86
Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med (1996) 0.86
Effect of verapamil on rhythmic contractions in isolated rat vasa deferentia [proceedings]. Br J Pharmacol (1980) 0.85
The effects of calcium channel inhibitors and other procedures affecting calcium translocation on drug-induced rhythmic contractions in the rat vas deferens. Br J Pharmacol (1983) 0.84
Phosphodiesterase IV inhibitors as therapy for eosinophil-induced lung injury in asthma. Environ Health Perspect (1994) 0.84
Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am J Respir Crit Care Med (1995) 0.84
Interaction between halothane and hydrostatic pressure. Br J Anaesth (1970) 0.84
The development of tone in the smooth muscle of guinea-pig isolated tracheal preparations may be influenced by prostanoids released from the adjacent airway cartilage. Prostaglandins (1987) 0.83
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist. J Pharmacol Exp Ther (1997) 0.83
Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist. J Pharmacol Exp Ther (1996) 0.82
Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea pig bladder. J Urol (2000) 0.82
The effects of calcium channel inhibitors on twitches and noradrenaline contractions of the rat bisected vas deferens. Eur J Pharmacol (1983) 0.82
The contractile effects of 5-hydroxytryptamine on the rat isolated vas deferens. Br J Pharmacol (1982) 0.81
Evidence that epithelium-dependent relaxation of vascular smooth muscle detected by co-axial bioassays is not attributable to hypoxia. Br J Pharmacol (1992) 0.81
In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists. Br J Pharmacol (1997) 0.81
Differences in time-related cardiopulmonary responses to hypoxia in three rat strains. Clin Exp Hypertens (2000) 0.80
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. J Med Chem (1996) 0.80
Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242. J Pharmacol Exp Ther (1997) 0.79
Food restriction-mediated adrenal influences on antigen-induced bronchoconstriction and airway eosinophil influx in the guinea pig. Int Arch Allergy Immunol (1998) 0.79
Chronic hypoxia-induced cardiopulmonary changes in three rat strains: inhibition by the endothelin receptor antagonist SB 217242. J Cardiovasc Pharmacol (1998) 0.79
Subcellular localization of leukotriene D4 receptors in sheep tracheal smooth muscle. Mol Pharmacol (1988) 0.79
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice. J Cardiovasc Pharmacol (2000) 0.79
Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog. J Pharmacol Exp Ther (1997) 0.79
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor. Eur J Pharmacol (2001) 0.79
Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig. J Pharmacol Exp Ther (1994) 0.78
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists. J Med Chem (2001) 0.78
The endothelins in the pulmonary system. Pulm Pharmacol (1996) 0.78
The dependence of airway smooth muscle on extracellular Ca2+ for contraction is influenced by the presence of cartilage. Life Sci (1986) 0.78
Influence of cartilage on reactivity and on the effectiveness of verapamil in guinea pig isolated airway smooth muscle. J Pharmacol Exp Ther (1987) 0.78
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework. J Med Chem (1997) 0.78
Characterization of NK3 receptors in rabbit isolated iris sphincter muscle. Br J Pharmacol (1997) 0.78
Differences in the ability of salbutamol to prevent and reverse LTC4-induced contractions of the guinea-pig isolated trachea: influence of l-serine borate. Eur J Pharmacol (1986) 0.77
SK&F 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4- and antigen-induced bronchoconstriction in cynomolgus monkeys. Pulm Pharmacol (1992) 0.77
An overview of species differences in the effects of a water extract of cotton bract on isolated airway smooth muscle, and effects of E. coli lipopolysaccharide. Environ Health Perspect (1986) 0.76
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412). J Med Chem (1999) 0.76
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin. Mol Pharmacol (2000) 0.76
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat. Pulm Pharmacol Ther (1999) 0.76
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma. J Pharmacol Exp Ther (1995) 0.76
Temporal and spatial patterns of sea lice levels on sea trout in western Scotland in relation to fish farm production cycles. Biol Lett (2010) 0.75
Calcium uptake into guinea-pig trachealis: the effect of epithelium removal. Cell Calcium (1987) 0.75
The effect of inhibitors of prostaglandin formation on contraction of the rat, rabbit and human vas deferens. J Auton Pharmacol (1990) 0.75
Pharmacologic profile of SK&F 104353, a novel, highly potent and selective peptidoleukotriene antagonist. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.75
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes. J Pharmacol Exp Ther (1989) 0.75
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity. Prostaglandins Leukot Essent Fatty Acids (1999) 0.75
KCl contractions in the rat intact and bisected vas deferens: contribution of endogenous noradrenaline release. Clin Exp Pharmacol Physiol (1983) 0.75
Hypoxia-induced pulmonary hypertension in an optimized environment for the guineapig. Lab Anim (1997) 0.75
Sensitivity changes in the smooth muscle of the guinea-pig isolated vas deferens after treatment of animals with 6-hydroxydopamine. J Pharmacol Exp Ther (1985) 0.75
The Photographic Plate as an Instrument in Nuclear Research Autoradiography and Radiation Monitoring. Science (1949) 0.75
Role of phosphatidylinositol turnover in the contraction of the rat aorta. Adv Exp Med Biol (1991) 0.75
Cysteinyl leukotriene receptor assays. Curr Protoc Pharmacol (2001) 0.75
The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist. Ann N Y Acad Sci (1991) 0.75
Inhibitory effect of streptonigrin on a murine sarcoma virus-induced tumor cell line (MSC) and selection of drug-resistant clones. In Vitro (1973) 0.75
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists. Farmaco (1999) 0.75